Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Rittgen

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Bulletin of Mathematical Biology|January 1, 1983
Controlled branching processes and their applications to normal and malignant haematopoiesisW Rittgen
Biometrics|December 29, 2000
SMR analysis of historical follow-up studies with missing death certificatesW Rittgen, N Becker
Anticancer Research|December 29, 2000
Cellular predictive factors for the drug response of lung cancerM Volm, W Rittgen
Mathematical Biosciences|February 1, 1992
Fitting cancer mortality data with cumulative damage modelsN Becker, W Rittgen
Mathematical Biosciences|April 1, 1994
Fitting epidemiologic follow-up studies with cumulative damage modelsN Becker, W Rittgen
Journal of Epidemiology and Biostatistics|February 8, 2002
Statistical issues of quality control in organised breast cancer screeningW Rittgen, N Becker
British Journal of Cancer|March 4, 1998
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomasM Volm, W Rittgen, P Drings
Journal of Cancer Research and Clinical Oncology|April 6, 2002
Symposium on mathematical, statistical, and computational methods for cancer surveillance and cancer screening. July 27, 2001 Heidelberg, Deutsches KrebsforschungszentrumL Edler, I Geisler, W Rittgen
International Journal of Cancer|June 30, 1998
Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinomaM Volm, R Koomägi, W Rittgen
Anticancer Research|August 6, 2000
Comparison of S100 protein and MIA protein as serum marker for malignant melanomaD Djukanovic, U Hofmann, A Sucker, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Bulletin of Mathematical Biology|January 1, 1983
Controlled branching processes and their applications to normal and malignant haematopoiesisW Rittgen
Biometrics|December 29, 2000
SMR analysis of historical follow-up studies with missing death certificatesW Rittgen, N Becker
Anticancer Research|December 29, 2000
Cellular predictive factors for the drug response of lung cancerM Volm, W Rittgen
Mathematical Biosciences|February 1, 1992
Fitting cancer mortality data with cumulative damage modelsN Becker, W Rittgen
Mathematical Biosciences|April 1, 1994
Fitting epidemiologic follow-up studies with cumulative damage modelsN Becker, W Rittgen
Journal of Epidemiology and Biostatistics|February 8, 2002
Statistical issues of quality control in organised breast cancer screeningW Rittgen, N Becker
British Journal of Cancer|March 4, 1998
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomasM Volm, W Rittgen, P Drings
Journal of Cancer Research and Clinical Oncology|April 6, 2002
Symposium on mathematical, statistical, and computational methods for cancer surveillance and cancer screening. July 27, 2001 Heidelberg, Deutsches KrebsforschungszentrumL Edler, I Geisler, W Rittgen
International Journal of Cancer|June 30, 1998
Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinomaM Volm, R Koomägi, W Rittgen
Anticancer Research|August 6, 2000
Comparison of S100 protein and MIA protein as serum marker for malignant melanomaD Djukanovic, U Hofmann, A Sucker, et al.
Pageof 3